Surgical Dressing Market Report 2026

The surgical dressing market size has grown strongly in recent years. It will grow from $3.91 billion in 2025 to $4.15 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increasing volume of surgical procedures, rising incidence of chronic wounds, growing aging population, improved access to surgical care facilities, wider adoption of sterile wound management practices.

The surgical dressing market size is expected to see strong growth in the next few years. It will grow to $5.36 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing demand for advanced wound care materials, rising focus on infection prevention, expansion of outpatient and home healthcare services, growing investments in innovative dressing technologies, increasing use of value-based healthcare models. Major trends in the forecast period include increasing demand for advanced absorbent dressings, rising adoption of antimicrobial wound care products, growing use of hydrocolloid and foam dressings, expansion of home-based wound care solutions, enhanced focus on faster wound healing outcomes.

The increasing volume of surgical procedures is expected to support the growth of the surgical dressing market in the coming years. Surgery is a medical discipline focused on treating diseases and injuries through manual or operative interventions. Factors such as an aging global population and the rising prevalence of chronic conditions are contributing to a higher number of surgical procedures worldwide. Surgical dressings are a vital element of post-operative wound management, playing an important role in infection prevention and the promotion of healing. They are used to protect surgical incisions, absorb excess exudate, and act as a barrier against bacteria and other external contaminants. Consequently, the growing number of surgical procedures is driving higher demand for surgical dressings. For example, in September 2023, according to the National Library of Medicine, a US-based federal government institution, as of 2023 there were 7,733 robotic surgical systems installed globally, and more than 10 million robotic surgeries had been performed. Therefore, the rise in surgical procedures is contributing to the expansion of the surgical dressing market.

Key players in the surgical dressing market are concentrating on the development of innovative all-in-one, extended-wear wound dressing solutions to improve healing outcomes and enhance patient care across healthcare environments. All-in-one, extended-wear wound dressings are single, integrated products that combine multiple wound care functions typically delivered by separate components and are designed for prolonged use. For instance, in September 2024, Solventum Corporation, a US-based healthcare company, introduced the V.A.C. Peel and Place Dressing, an integrated dressing that can be applied in under two minutes and worn for up to seven days. This product represents the next generation of V.A.C. Therapy, featuring an all-in-one dressing and drape design that streamlines application while reducing the time and training required for dressing placement and changes.

In August 2023, Coloplast, a Denmark-based medical device company, acquired Kerecis for an undisclosed consideration. Through this acquisition, Coloplast aims to broaden its wound care portfolio, reinforce its position in regenerative medicine, and improve patient outcomes through advanced tissue repair solutions. Kerecis is an Iceland-based company that specializes in regenerative tissue products derived from fish skin, offering grafts that promote wound healing and tissue regeneration in chronic and complex wounds.

Major companies operating in the surgical dressing market are 3M Company, Smith & Nephew plc, Mölnlycke Health Care AB, Convatec Group Plc., Johnson & Johnson, Coloplast Corp, Medline Industries LP, Advancis Medical, B. Braun SE, Baxter International Inc., Derma Sciences Inc., Organogenesis Holdings Inc., Essity Aktiebolag, BSN Medical GmbH, DeRoyal Industries Inc., Lohmann & Rauscher GmbH & Co. KG, Paul Hartmann AG, Winner Medical Co. Ltd., McKesson Medical-Surgical Inc., Hollister Incorporated, Integra LifeSciences Corporation, DermaRite Industries LLC.

North America was the largest region in the surgical dressing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the surgical dressing market report during the forecast period. The regions covered in the surgical dressing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the surgical dressing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the surgical dressing market by increasing costs of imported raw materials such as medical-grade textiles, polymers, adhesives, and antimicrobial agents used in advanced dressing products. Hospitals and specialty clinics in North America and Europe are particularly affected due to dependence on imported wound care supplies, while Asia-Pacific faces pricing pressure on exported dressing products. These tariffs are raising procurement costs and influencing purchasing decisions. However, they are also encouraging domestic manufacturing of surgical dressings, local sourcing of raw materials, and innovation in cost-effective wound care solutions.

The surgical dressing market research report is one of a series of new reports that provides surgical dressing market statistics, including surgical dressing industry global market size, regional shares, competitors with a surgical dressing market share, detailed surgical dressing market segments, market trends and opportunities, and any further data you may need to thrive in the surgical dressing industry. This surgical dressing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A surgical dressing is a sterile material used to cover and protect a wound, designed to absorb and retain fluids such as blood and exudate from damaged tissue. It also covers surgical incisions to prevent stitches or staples from adhering to clothing.

The main products in the surgical dressing market include primary dressings, secondary dressings, and other related products. Primary dressings are applied directly to the wound surface. Surgical dressings are used in procedures related to diabetes-related surgeries, cardiovascular diseases, ulcers, burns, transplant sites, and other applications, and are utilized by hospitals, specialty clinics, home healthcare providers, ambulatory surgery centers, and other end users.

The surgical dressing market consists of sales of gauze, foam, transparent film, hydrocolloid, and hydrogel. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.